Metabolic Liver Disease: Integrating Care in Diabetes

Created using ChatSlide

This presentation explores the evolving landscape of MASLD in 2026, emphasizing its implications in Type 2 Diabetes (T2D) and obesity. It covers the continuum from MASLD to advanced liver disease, highlighting the importance of fibrosis staging in prognosis. The session will address effective diabetes clinic strategies for identifying high-risk patients, the role of noninvasive testing in fibrosis assessment, and treatment options ranging from weight loss to targeted therapies. Finally, it...